A study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).
The Drugs Controller General Of India (DCGI), India s drug regulator, has approved a proposal for a study to be conducted on the mixing of two COVID-19 vaccines Covishield and Covaxin. According to reports, the study and related trials will be conducted at Christian Medical College in Vellore, Ta
கடந்த 100 ஆண்டுகளாக காசநோய்க்கு சிகிச்சையளிக்கப் பயன்படுத்தப்படும் பிசிஜி தடுப்பூசி கோவிட் -19 நோய்த்தொற்றின் அபாயத்தைத் தடுக்க உதவும் என்று இந்திய மருத்துவ ஆராய்ச்சி கவுன்சில் தெரிவித்துள்ளது
The Indian Council of Medical Research has revealed that a mix of Covishield and Covaxin, the two main vaccines of India's Covid vaccination programme, can actually yield better results. The study has now got the go-ahead by the Drugs Controller General Of India (DCGI) for further research and clinical trials
એક્સપર્ટ કમિટીની ભલામણ અનુસાર
નવી દિલ્હી તા. ૧૧ઃ વેક્સિનના મિક્સીંગ માટે ભારત એક ડગલું વધુ આગળ વધ્યું છે. કોવેક્સિન અને કોવિશીલ્ડ મિક્સીંગ માટે ડીસીજીઆઈની મંજુરી મળી ગઈ છે. કેન્દ્રિય દવા નિયામકની સબ્જેક્ટ એક્સપર્ટ કમિટીએ ૨૯ જુલાઈએ આ સ્ટડી કરાવવા માટે સલાહ આપી હતી.
કોરોના વાયરસની બે રસીના મિક્સીંગ પર ભારત એક